Abstract
Among neurodegenerative diseases, Alzheimer disease (AD) is a leading cause of death in elderly individuals. AD is characterized, among other clinical findings, by unexplained weight loss, cachexia and altered immune function. Alteration in energy balance and nutritional status are relayed to the feeding-related hypothalamic nuclei by neuronal pathways and/or via alterations in the levels of eating-controlling hormones. The adipocyte-derived hormone, leptin, and the pancreatic-derived peptide, insulin, function as hormonal signaling mechanisms for fat deposition and play a key role in regulating food intake, body weight and energy homeostasis via their actions on specific hypothalamic nuclei. Moreover, leptin, insulin and their receptors are widely expressed in many hypothalamic and extra-hypothalamic brain regions indicating that these hormones may have other neuronal functions. Although emerging evidence supports the role of insulin resistance in the development of AD, the potential involvement of leptin in the pathogenic process of AD has been proposed only recently. Here we review recent reports and progress concerning the molecular mechanism and the potential role of leptin and insulin in AD.
Keywords: Leptin, insulin, signal transduction, Alzheimer disease, review
Central Nervous System Agents in Medicinal Chemistry
Title: Alzheimer Disease: What Role for Leptin and Insulin?
Volume: 6 Issue: 4
Author(s): Sami Dridi, D. Dominguez and J. Buyse
Affiliation:
Keywords: Leptin, insulin, signal transduction, Alzheimer disease, review
Abstract: Among neurodegenerative diseases, Alzheimer disease (AD) is a leading cause of death in elderly individuals. AD is characterized, among other clinical findings, by unexplained weight loss, cachexia and altered immune function. Alteration in energy balance and nutritional status are relayed to the feeding-related hypothalamic nuclei by neuronal pathways and/or via alterations in the levels of eating-controlling hormones. The adipocyte-derived hormone, leptin, and the pancreatic-derived peptide, insulin, function as hormonal signaling mechanisms for fat deposition and play a key role in regulating food intake, body weight and energy homeostasis via their actions on specific hypothalamic nuclei. Moreover, leptin, insulin and their receptors are widely expressed in many hypothalamic and extra-hypothalamic brain regions indicating that these hormones may have other neuronal functions. Although emerging evidence supports the role of insulin resistance in the development of AD, the potential involvement of leptin in the pathogenic process of AD has been proposed only recently. Here we review recent reports and progress concerning the molecular mechanism and the potential role of leptin and insulin in AD.
Export Options
About this article
Cite this article as:
Dridi Sami, Dominguez D. and Buyse J., Alzheimer Disease: What Role for Leptin and Insulin?, Central Nervous System Agents in Medicinal Chemistry 2006; 6 (4) . https://dx.doi.org/10.2174/187152406779010877
DOI https://dx.doi.org/10.2174/187152406779010877 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets Synthesis of Xanthones and Benzophenones as Inhibitors of Tumor Cell Growth
Letters in Drug Design & Discovery Adenoviral Vectors for Cancer Gene Therapy
Current Genomics Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression
Current Topics in Medicinal Chemistry Methamphetamine and HIV Infection, Role in Neurocognitive Dysfunction
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Combination Therapy of Intraperitoneal Rapamycin and Convection- Enhanced Delivery of Nanoliposomal CPT-11 in Rodent Orthotopic Brain Tumor Xenografts
Current Cancer Drug Targets Therapeutic Development of Interrelated Metabolic and Neurodegenerative Disorders
Current Pharmaceutical Design Death Receptor Signaling in Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Pathophysiology and Treatment of Diabetic Peripheral Neuropathy: The Case for Diabetic Neurovascular Function as an Essential Component
Current Diabetes Reviews Extranuclear Localization of SIRT1 and PGC-1α: An Insight into Possible Roles in Diseases Associated with Mitochondrial Dysfunction
Current Molecular Medicine Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen
Current Pharmaceutical Design Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes
Current Gene Therapy The Physiological Characteristics and Transcytosis Mechanisms of the Blood-Brain Barrier (BBB)
Current Pharmaceutical Biotechnology Chemoprotection and Selection by Chemotherapy of Multidrug Resistance-associated Protein-1 (MRP1) Transduced Cells
Current Gene Therapy A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration
Current Neuropharmacology Protein Oxidative Folding in the Intermembrane Mitochondrial Space: More than Protein Trafficking
Current Protein & Peptide Science New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry Anti-Angiogenic Therapies for Children with Cancer
Current Cancer Drug Targets A Transient Survival Model of Alteration of Electrophysiological Properties Due to Amyloid Beta Toxicity Based on SH-SY5Y Cell Line
Current Alzheimer Research Differential Susceptibility of Naive and Differentiated PC-12 Cells to Methylglyoxal-Induced Apoptosis: Influence of Cellular Redox
Current Neurovascular Research